Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

THe hoopla is premature

February 26, 2008

Analysis of:Daring to Think Differently About Schizophrenia | www.nytimes.com

The clinical trial which was done has shown only comparable efficacy to available treatment for positive symptoms. It did not study efficacy for cognition or negative symptoms. It did not test efficacy in treatment resistant patients. It did not show long term efficacy. It did not show that in combination with existing treatments it adds efficacy.

Page : 11 to 1 of 1

Subscribe to Updates

By RSS